e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Obesity and severity of nocturnal desaturations have synergestic effects on the increased urinary excretion of leukotriene E
4
in sleep apnea syndrome
F. Stanke-Labesque, R. Tamisier, B. Lefebrve, J. P. Baguet, N. Arnol, P. Levy, J. L. Pepin (Grenoble, France)
Source:
Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Session:
Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Session type:
E-Communication Session
Number:
3234
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Stanke-Labesque, R. Tamisier, B. Lefebrve, J. P. Baguet, N. Arnol, P. Levy, J. L. Pepin (Grenoble, France). Obesity and severity of nocturnal desaturations have synergestic effects on the increased urinary excretion of leukotriene E
4
in sleep apnea syndrome. Eur Respir J 2008; 32: Suppl. 52, 3234
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Clinical case discussion: ERS guidelines on high flow nasal cannula in acute respiratory failure: from the clinical cases to the scientific evidence
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
Related content which might interest you:
Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP
Source: Eur Respir J 2007; 30: 496-500
Year: 2007
Urinary excretion of erythropoietin in sleep apnea-hypopnea syndrome
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012
Neuropeptide plasma levels in sleep apnea patients with and without excessive daytime sleepiness
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009
Sleep fragmentation and nocturnal desaturation in obstruction sleep apnoea with and without COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 573s
Year: 2002
Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea: Effect of continuous positive airway pressure treatment
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Sleep and daytime sleepiness in upper airway resistance syndrome compared to obstructive sleep apnoea syndrome
Source: Eur Respir J 2001; 17: 838-847
Year: 2001
Peculiarities of GABA levels in plasma and urine of asthma patients with obstructive sleep apnea
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020
Renin and aldosterone levels in obstructive sleep apnea syndrome patients
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015
Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Year: 2021
Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea
Source: Sleep and Breathing Conference 2021
Year: 2021
Effects of reduced lung volumes and age on oxyhemoglobin nocturnal desaturation in obstructive sleep apnea patients before and after CPAP treatment
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II
Year: 2011
Correlations between severity of nocturnal hypoxemia and level of Galectin-3 in obstructive sleep apnea patients
Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view
Year: 2019
Association between daytime hypersomnolence and the metabolic syndrome in men with obstructive sleep apnea
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009
The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea
Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Year: 2019
The factors related to the daytime hypercapnia in obstructive sleep apnea syndrome
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009
Leptin daytime urine secretion corresponds to OSA severity
Source: Eur Respir J 2004; 24: Suppl. 48, 566s
Year: 2004
Correlation between intermittent nocturnal hypercapnia and depressive symptoms in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
Prevalance of daytime hypercapnia in patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 574s
Year: 2002
Plasma orexin-A levels in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept